APNAR PHARMA Competitors

TEDOR Pharma Services is a science-driven Contract, testing, Drug Development, and Manufacturing Organization (CDMO). partnering with your team to provide solutions and services for analytical testing; drug dosage development; clinical supply, packaging, distribution; and commercial manufacturing. DEA-scheduled products I-V; high potency; powder biologics; small manufacturing batches and orphan drugs for life science customers. TEDOR has helped customers meet their project timelines, achieve regulatory approvals, and solve formulation challenges. TEDOR Pharma employs skilled and specialized experts that support a wide range of capabilities that include: •Drug Product Development • Analytical Testing • Quality Assurance • Legal Compliance • Regulatory Filing • cGMP Manufacturing • Commercialization Our dynamic work environment provides a great opportunity to learn and grow professionally. We offer competitive wages and benefits, and our employees have the opportunity to drive innovative technologies, setting industry trends. TEDOR is an Equal Opportunity Employer.

Dow Development Laboratories (DDL) designs, develops, tests and manufactures topical drug products, including creams, gels, ointments, pastes, solutions, and suspensions. The company has specialized expertise in formulating small molecules, peptides, proteins, new chemical entities, combination products and generics. The project teams apply their topical product development experience and customer service focus on clients' programs, taking a concept through formulation development, screening, non-clinical studies and clinical supplies, toward successful regulatory approval. DDL has extensive expertise in the following areas: Formulation Development and Optimization, following QbD principles and always with the patient in mind Analytical Method Development and Validation R&D, GLP and GMP Clinical Supplies Manufacturing Clinical Labeling and Distribution ICH Stability (reach-in and walk-in chambers) In Vitro Release Testing (IVRT) CMC Program Strategy and Pharmaceutical Development Reports

Based in North Brunswick, New Jersey, Ascendia Pharmaceuticals is a specialty contract development and manufacturing (CDMO) company dedicated to delivering sophisticated formulations of existing drug products, and enabling formulations for preclinical- and clinical-stage drug candidates. Ascendia Pharmaceuticals is your ideal partner for: · Early stage IND-enabling formulations for toxicology and pharmacokinetic (PK) studies · Rapid development through Phase I CTM materials for oral and parenteral dosage forms · Fast discovery formulation support · Formulation development and CTM manufacturing for specialty pharmaceuticals Ascendia Pharmaceuticals also provides special development programs: · Formulations for poorly soluble and low bioavailability drugs · First-in-man injectable formulations · Nano-emulsion and nano-particle formulations · Peptide formulations · Sustained release by parenteral or oral routes · Development of 505(b)(2) products · Development of complex generics · High potency and DEA controlled drug substances · Ocular formulation development · Animal health formulations